Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
infliximab | tumor necrosis factor | biotech | Successful target | TTD , drugbank , DGIDB | Arthritis Psoriatic[MeSHID:D015535] Rectovaginal Fistula[MeSHID:D012006] Maintenance[MeSHID:D008283] Crohn Disease[MeSHID:D003424] Physical Examination[MeSHID:D010808] Rheumatoid Arthritis[MeSHID:D001172] Ankylosing spondylitis[MeSHID:D013167] Ulcerative Colitis[MeSHID:D003093] Disease Progression[MeSHID:D018450] Mucous Membrane[MeSHID:D009092] Senile Plaques[MeSHID:D058225] Arthritis[MeSHID:D001168] Cardiac Arrest[MeSHID:D006323] Dental Plaque[MeSHID:D003773] Psoriasis[MeSHID:D011565] pathologic fistula[MeSHID:D005402] Wound Healing[MeSHID:D014945] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Asthma[MeSHID:D001249] |
1.59 | approved | inhibitor |
infliximab | tumor necrosis factor | biotech | Successful target | TTD , drugbank , DGIDB | Arthritis Psoriatic[MeSHID:D015535] Rectovaginal Fistula[MeSHID:D012006] Maintenance[MeSHID:D008283] Crohn Disease[MeSHID:D003424] Physical Examination[MeSHID:D010808] Rheumatoid Arthritis[MeSHID:D001172] Ankylosing spondylitis[MeSHID:D013167] Ulcerative Colitis[MeSHID:D003093] Disease Progression[MeSHID:D018450] Mucous Membrane[MeSHID:D009092] Senile Plaques[MeSHID:D058225] Arthritis[MeSHID:D001168] Cardiac Arrest[MeSHID:D006323] Dental Plaque[MeSHID:D003773] Psoriasis[MeSHID:D011565] pathologic fistula[MeSHID:D005402] Wound Healing[MeSHID:D014945] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.59 | approved | inhibitor |
click here to return to the previous page |